INFLUENZA PREVENTION
Clinical trials for INFLUENZA PREVENTION explained in plain language.
Never miss a new study
Get alerted when new INFLUENZA PREVENTION trials appear
Sign up with your email to follow new studies for INFLUENZA PREVENTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New experimental flu vaccine begins human testing
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage study tests an experimental flu vaccine called FluMos-v2, with or without an added booster (ALFQ), in 45 healthy adults aged 18-50. Participants receive two shots, four months apart, and are monitored for safety and immune response over 15 months. The goal is to …
Matched conditions: INFLUENZA PREVENTION
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 09:28 UTC
-
New Stem-Based flu vaccine enters human testing
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage study tests a new flu vaccine designed to target the stable stem part of the flu virus, aiming for broader protection. Healthy adults aged 18-50 who have had a flu shot since 2020 will receive two doses, with or without an adjuvant to boost the immune response. T…
Matched conditions: INFLUENZA PREVENTION
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 14:03 UTC